Filing Details

Accession Number:
0001104659-22-066221
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-31 07:13:23
Reporting Period:
2022-05-27
Accepted Time:
2022-05-31 07:13:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1012477 Avadel Pharmaceuticals Plc AVDL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1410677 J Gregory Divis C/O Avadel Pharmaceuticals Plc
10 Earlsfort Terrace
Dublin 2 L2 D02 T380
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Adss Acquisiton 2022-05-27 50,000 $2.05 149,100 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.